University of Massachusetts, Memorial Medical Center
Worcester, Massachusetts 06155
14 studies enrolling now · 171 studies all time
What they study most
ALS, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT, Advanced Breast Cancer, Amyotrophic Lateral Sclerosis, Ascites, Atrial Fibrillation, B-cell Malignancy, Becker Muscular Dystrophy, Bladder Cancer, Bladder Perforation
Studies at this site
- Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis — Recruiting now
- Continuous Glucose Monitor Use in Pregnancy — Recruiting now
- Letrozole in Uterine Leiomyosarcoma — Recruiting now
- Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
- Preventing T2DM After GDM With Immediate Postpartum Screening — Recruiting now
- A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
- Preoperative Fasting vs. Not Fasting in Critically Ill Patients — Recruiting now
- International Registry for Men With Advanced Prostate Cancer (IRONMAN) — Recruiting now
- Early Detection of Gestational Diabetes Mellitus in Pregnancy — Recruiting now
- 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism — Recruiting now
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years — Recruiting now
- Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) — Recruiting now
- AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma — Recruiting now
- Mirai-MRI: Validation of AI Models for Breast Cancer Risk — Recruiting now
- Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings — Recruiting now
- CHAMPION-AF Clinical Trial — Running, not enrolling
- Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) — Running, not enrolling
- Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy — Enrolling by invitation
- SIMPLAAFY Clinical Trial — Running, not enrolling
- RECOVER-SLEEP: Platform Protocol — Completed
- Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis — Stopped early
- Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) — Running, not enrolling
- A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) — Running, not enrolling
- Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) — Stopped early
- Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy — Running, not enrolling
- Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) — Stopped early
- Open Label Extension Study of AMX0035 in Patients With ALS — Completed
- Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes — Withdrawn before enrolling
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): — Stopped early
- Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
- Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury — Completed
- Palbociclib in Real World Practice — Completed
- Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) — Completed
- Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus — Completed
- AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
- Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A — Completed
- A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
- Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma — Stopped early
- Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
- A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery — Completed
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium — Completed
- Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer — Completed
- Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes — Completed
- Combination Chemotherapy in Treating Women With Breast Cancer — Completed
- Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed
- A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
- Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas — Completed
- Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study) — Running, not enrolling
- Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification — Completed
- Effect of Preoperative Fiber on Postoperative Bowel Function — Completed